Integration into multimodal treatment platforms, particularly immunotherapy and radiotherapy, should be prioritized given FAK’s immunomodulatory functions and the immunologically ‘cold’ tumor microenvironment typical of many CNS tumors (98). Here, PTK2 is linked to neoplasm.